Evidence map›Paper›PMID 34056243›Full record

ArticleACS omega2021

Toxicological Screening of 4-Phenyl-3,4-dihydrobenzo[

Fareeha Anwar, Uzma Saleem, Atta Ur Rehman, Bashir Ahmad, Tariq Ismail, Muhammad Usman Mirza, Lee Yean Kee, Iskandar Abdullah, Sarfraz Ahmad

RetractedAbstract readRetracted Publication
In one paragraph

Article in ACS omega, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Fareeha AnwarRiphah Institute of Pharmaceutical Sciences, Riphah International University, Lahore 54000 Pakistan.ORCID 0000-0001-5097-8128
Uzma SaleemDepartment of Pharmacology, Faculty of Pharmaceutical Sciences, Govt. College University, Faisalabad 38040, Pakistan.ORCID 0000-0002-1541-4236
Atta Ur RehmanDepartment of Pharmacy, Forman Christian College, Lahore 54600, Pakistan.
Bashir AhmadRiphah Institute of Pharmaceutical Sciences, Riphah International University, Lahore 54000 Pakistan.
Tariq IsmailDepartment of Pharmacy, COMSATS Institute of Information Technology, Abbottabad Campus, Abottabad 22060, Pakistan.
Muhammad Usman MirzaDepartment of Pharmaceutical and Pharmacological Sciences, Rega Institute for Medical Research, Medicinal Chemistry, University of Leuven, Leuven B-3000, Belgium.
Lee Yean KeeDrug Design and Development Research Group (DDDRG), Department of Chemistry, Faculty of Science, Universiti Malaya, Kuala Lumpur 50603, Malaysia.
Iskandar AbdullahDrug Design and Development Research Group (DDDRG), Department of Chemistry, Faculty of Science, Universiti Malaya, Kuala Lumpur 50603, Malaysia.
Sarfraz AhmadDrug Design and Development Research Group (DDDRG), Department of Chemistry, Faculty of Science, Universiti Malaya, Kuala Lumpur 50603, Malaysia.ORCID 0000-0003-0059-477X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toxicity studies are necessary for the development of a new drug. Naphthalene is a bicyclic molecule and is easy to derivatize. In our previous study, a derivative of naphthalene (4-phenyl,3,4-dihydrobenzoquinoline-2(

Identifiers

PMID34056243
PMCPMC8153932

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.